- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.94 Å
- Oligo State
- hetero-3-2-mer
- Ligands
- 8 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 8 x OCT: N-OCTANE(Non-covalent)
OCT.3: 5 residues within 4Å:- Chain A: F.885, L.886, W.895
- Chain C: I.17
- Ligands: DDQ.88
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:W.895, A:W.895
OCT.7: 3 residues within 4Å:- Chain A: V.382, A.385, F.386
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:F.386, A:F.386, A:F.386
OCT.58: 7 residues within 4Å:- Chain A: I.17
- Chain B: I.882, F.885, L.886, W.895
- Ligands: C14.4, D12.49
2 PLIP interactions:2 interactions with chain B- Hydrophobic interactions: B:W.895, B:W.895
OCT.60: 10 residues within 4Å:- Chain A: V.454, P.455, F.458, L.876, I.879, V.883
- Chain C: L.21, A.22, L.25, K.29
4 PLIP interactions:3 interactions with chain A, 1 interactions with chain C- Hydrophobic interactions: A:F.458, A:F.458, A:F.458, C:K.29
OCT.64: 10 residues within 4Å:- Chain C: S.523, T.524, H.526, Y.527, S.530, L.972, L.976, I.1019, F.1020
- Ligands: LMT.63
No protein-ligand interaction detected (PLIP)OCT.74: 9 residues within 4Å:- Chain B: F.4, F.11, V.14, I.18
- Chain C: M.447, C.887, A.890, L.891
- Ligands: LMT.68
4 PLIP interactions:1 interactions with chain C, 3 interactions with chain B- Hydrophobic interactions: C:A.890, B:F.11, B:F.11, B:I.18
OCT.80: 8 residues within 4Å:- Chain C: I.27, V.32, I.337, V.341, L.344, F.380, I.390, M.395
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:L.344, C:F.380, C:I.390
OCT.90: 11 residues within 4Å:- Chain C: M.552, A.553, F.556, V.557, Y.877, L.881, V.905, V.909, L.913, L.931, I.935
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:F.556, C:F.556, C:Y.877
- 2 x C14: TETRADECANE(Non-covalent)
C14.4: 7 residues within 4Å:- Chain A: W.13, I.17, R.363, T.495, M.496
- Chain B: W.895
- Ligands: OCT.58
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:W.13
C14.66: 10 residues within 4Å:- Chain B: L.25, K.29
- Chain C: V.454, P.455, F.458, F.459, G.460, Q.872, I.879, V.883
7 PLIP interactions:7 interactions with chain C- Hydrophobic interactions: C:V.454, C:F.458, C:F.458, C:F.458, C:F.459, C:F.459, C:V.883
- 14 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.6: 7 residues within 4Å:- Chain A: Y.811
- Chain E: L.19, E.20, R.23, D.44, V.45, L.53
3 PLIP interactions:2 interactions with chain E, 1 interactions with chain A- Hydrogen bonds: E:R.23, E:D.44
- Water bridges: A:Y.811
EDO.29: 8 residues within 4Å:- Chain A: Q.218, N.231, A.232, S.233
- Chain B: S.84, G.581, T.724, P.814
6 PLIP interactions:2 interactions with chain A, 4 interactions with chain B- Water bridges: A:Q.218, A:S.233, B:S.84, B:G.581
- Hydrogen bonds: B:S.84, B:T.724
EDO.33: 8 residues within 4Å:- Chain B: L.111, Q.112, M.115, G.126, V.127
- Chain C: Q.112, M.115, P.116
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:V.127
EDO.34: 6 residues within 4Å:- Chain A: D.101
- Chain B: N.74, T.98, D.99, I.102
- Ligands: EDO.59
2 PLIP interactions:2 interactions with chain B- Hydrogen bonds: B:D.99
- Water bridges: B:N.74
EDO.40: 4 residues within 4Å:- Chain B: S.537, T.538, G.539, R.540
4 PLIP interactions:4 interactions with chain B- Hydrogen bonds: B:G.539, B:R.540, B:R.540, B:R.540
EDO.41: 6 residues within 4Å:- Chain B: R.418, Q.437, F.948, D.951, L.952, M.970
2 PLIP interactions:2 interactions with chain B- Water bridges: B:R.418, B:Q.437
EDO.53: 11 residues within 4Å:- Chain B: Y.325, P.326, Y.327, D.328, T.329, P.331, Q.569, G.570, V.571, S.630, L.631
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:D.328, B:Q.569, B:L.631
EDO.54: 7 residues within 4Å:- Chain B: S.46, A.47, S.48, Q.125, G.126, V.127, S.128
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:S.48, B:Q.125, B:S.128
EDO.55: 9 residues within 4Å:- Chain B: F.727, I.729, P.783, I.786, S.802, S.805, S.806, S.807
- Chain D: L.79
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:P.783
EDO.56: 8 residues within 4Å:- Chain A: Q.124, R.239
- Chain B: P.116, L.117, L.118, P.119, Q.120, Q.123
4 PLIP interactions:3 interactions with chain B, 1 interactions with chain A- Water bridges: B:P.116, B:Q.120, B:Q.123
- Hydrogen bonds: A:Q.124
EDO.59: 7 residues within 4Å:- Chain A: D.99, I.102
- Chain B: I.102
- Chain C: D.99, D.101, I.102
- Ligands: EDO.34
3 PLIP interactions:1 interactions with chain A, 2 interactions with chain C- Hydrogen bonds: A:D.99, C:D.99
- Water bridges: C:D.101
EDO.70: 9 residues within 4Å:- Chain A: S.84, A.580, G.581, T.724, P.814
- Chain C: Q.218, N.231, A.232, S.233
7 PLIP interactions:3 interactions with chain C, 4 interactions with chain A- Hydrogen bonds: C:Q.218, C:N.231, C:S.233, A:G.581, A:T.724, A:T.724
- Water bridges: A:S.84
EDO.71: 9 residues within 4Å:- Chain A: L.113
- Chain C: S.46, A.47, S.48, T.87, Q.125, G.126, V.127, S.128
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:A.47, C:S.128
EDO.72: 8 residues within 4Å:- Chain C: L.674, G.675, T.676, A.677, D.681, N.719, E.826, L.828
6 PLIP interactions:6 interactions with chain C- Hydrogen bonds: C:T.676, C:A.677, C:A.677
- Water bridges: C:D.681, C:D.681, C:D.681
- 39 x GOL: GLYCEROL(Non-functional Binders)
GOL.8: 7 residues within 4Å:- Chain A: E.693, Q.726, E.810, Y.811, G.812
- Chain E: Y.56, F.90
Ligand excluded by PLIPGOL.9: 12 residues within 4Å:- Chain A: F.727, I.729, I.786, G.787, F.801, S.802, S.805, S.806, S.807
- Chain E: L.79, N.112, K.144
Ligand excluded by PLIPGOL.10: 4 residues within 4Å:- Chain A: D.745, R.792, A.793, A.794
Ligand excluded by PLIPGOL.11: 8 residues within 4Å:- Chain A: I.685, Q.687, Y.819, N.820, L.822, D.858
- Chain C: E.309, K.312
Ligand excluded by PLIPGOL.12: 8 residues within 4Å:- Chain A: D.566, E.567, D.568, W.634, K.643, G.994, S.997, G.998
Ligand excluded by PLIPGOL.13: 5 residues within 4Å:- Chain A: T.600, K.601, E.602, K.603, N.604
Ligand excluded by PLIPGOL.14: 7 residues within 4Å:- Chain A: W.187, E.269, Y.275, E.776, A.777, R.780
- Chain C: P.223
Ligand excluded by PLIPGOL.15: 11 residues within 4Å:- Chain A: P.50, G.51, R.185, E.273, N.274, Y.275, G.755, G.756, Y.772, M.774
- Ligands: GOL.27
Ligand excluded by PLIPGOL.16: 10 residues within 4Å:- Chain A: Q.181, E.273, Y.758, D.761, V.768, K.769, K.770
- Chain B: V.64, Q.67, L.117
Ligand excluded by PLIPGOL.17: 11 residues within 4Å:- Chain A: G.217, Q.218, G.221, T.222
- Chain B: G.51, T.85, D.276, W.754, G.755, M.774
- Ligands: GOL.38
Ligand excluded by PLIPGOL.21: 9 residues within 4Å:- Chain A: T.44, S.46, Q.89, E.130, S.132, S.133, S.134, D.174, K.292
Ligand excluded by PLIPGOL.25: 10 residues within 4Å:- Chain A: A.165, R.168, T.169, S.170, E.309
- Chain B: L.75, M.76, Y.77, M.78, N.820
Ligand excluded by PLIPGOL.26: 8 residues within 4Å:- Chain A: I.743, N.744, N.747
- Chain C: K.208, A.209, A.212, V.214, Q.237
Ligand excluded by PLIPGOL.27: 10 residues within 4Å:- Chain A: G.51, T.85, W.754, G.755, M.774
- Chain C: G.217, Q.218, G.221, T.222
- Ligands: GOL.15
Ligand excluded by PLIPGOL.28: 7 residues within 4Å:- Chain A: T.696, Q.697, N.700
- Chain E: R.23, A.24, W.57, H.59
Ligand excluded by PLIPGOL.36: 8 residues within 4Å:- Chain B: N.189, E.192, R.263, D.264, V.265, A.266, K.267, E.776
Ligand excluded by PLIPGOL.38: 11 residues within 4Å:- Chain B: P.50, R.185, E.273, N.274, Y.275, G.755, G.756, S.757, Y.772, M.774
- Ligands: GOL.17
Ligand excluded by PLIPGOL.39: 6 residues within 4Å:- Chain B: Q.210, L.240, E.245, K.248, I.249, L.250
Ligand excluded by PLIPGOL.44: 4 residues within 4Å:- Chain B: D.153, Y.182, E.269, L.270
Ligand excluded by PLIPGOL.45: 6 residues within 4Å:- Chain A: R.765, G.766
- Chain B: K.55, G.691, H.692, E.693
Ligand excluded by PLIPGOL.46: 8 residues within 4Å:- Chain B: E.693, Q.726, E.810, Y.811, G.812
- Chain D: Y.56, F.90
- Ligands: GOL.91
Ligand excluded by PLIPGOL.47: 7 residues within 4Å:- Chain B: R.699, N.700, L.703, P.718, E.722
- Chain D: A.24, R.26
Ligand excluded by PLIPGOL.48: 6 residues within 4Å:- Chain B: D.566, F.666, N.667, L.668, P.669, T.676
Ligand excluded by PLIPGOL.62: 10 residues within 4Å:- Chain B: Q.218, N.231, A.232, S.233
- Chain C: S.84, G.621, Q.622, T.724, P.814
- Ligands: GOL.85
Ligand excluded by PLIPGOL.69: 8 residues within 4Å:- Chain C: R.185, E.273, N.274, Y.275, G.755, G.756, Y.772, M.774
Ligand excluded by PLIPGOL.75: 10 residues within 4Å:- Chain A: V.64, Q.67, L.117
- Chain C: Q.181, E.273, Y.758, D.761, V.768, K.769, K.770
Ligand excluded by PLIPGOL.76: 10 residues within 4Å:- Chain C: D.566, E.567, D.568, K.643, T.993, G.994, A.995, G.996, S.997, G.998
Ligand excluded by PLIPGOL.77: 6 residues within 4Å:- Chain C: K.342, I.991, S.992, T.993, G.994
- Ligands: GOL.78
Ligand excluded by PLIPGOL.78: 5 residues within 4Å:- Chain C: E.339, K.342, T.993, G.994
- Ligands: GOL.77
Ligand excluded by PLIPGOL.81: 9 residues within 4Å:- Chain A: M.76, Y.77, N.820
- Chain C: A.165, R.168, T.169, S.170, E.309, K.312
Ligand excluded by PLIPGOL.82: 8 residues within 4Å:- Chain A: G.689
- Chain C: A.160, N.161, D.764, R.765, G.766, R.767, K.769
Ligand excluded by PLIPGOL.83: 6 residues within 4Å:- Chain C: T.243, E.244, G.247, R.263, K.267, I.268
Ligand excluded by PLIPGOL.84: 7 residues within 4Å:- Chain B: P.223
- Chain C: W.187, K.267, E.269, E.776, A.777, R.780
Ligand excluded by PLIPGOL.85: 11 residues within 4Å:- Chain C: D.83, S.84, T.85, A.618, G.619, R.620, G.621, L.721, P.814, R.815
- Ligands: GOL.62
Ligand excluded by PLIPGOL.89: 3 residues within 4Å:- Chain C: G.511, F.512, W.515
Ligand excluded by PLIPGOL.91: 6 residues within 4Å:- Chain B: E.693
- Chain D: Y.56, W.57, F.90, H.92
- Ligands: GOL.46
Ligand excluded by PLIPGOL.92: 7 residues within 4Å:- Chain B: T.696, Q.697, N.700
- Chain D: R.23, A.24, W.57, H.59
Ligand excluded by PLIPGOL.93: 7 residues within 4Å:- Chain B: P.725, Y.811
- Chain D: L.19, E.20, R.23, D.44, L.53
Ligand excluded by PLIPGOL.94: 9 residues within 4Å:- Chain B: D.732, S.806
- Chain D: I.114, H.118, N.122, D.143, F.145, K.147, I.152
Ligand excluded by PLIP- 4 x D12: DODECANE(Non-covalent)
D12.18: 12 residues within 4Å:- Chain A: V.382, F.386, V.454, A.457, F.458, R.468, I.472, V.475, S.476, A.479
- Ligands: D12.20, HEX.61
5 PLIP interactions:5 interactions with chain A- Hydrophobic interactions: A:F.386, A:A.457, A:F.458, A:F.458, A:V.475
D12.20: 13 residues within 4Å:- Chain A: M.1, V.443, A.446, M.447, S.450, V.454, V.475, A.479, V.482, L.483, L.486
- Ligands: D12.18, HEX.19
2 PLIP interactions:2 interactions with chain A- Hydrophobic interactions: A:A.479, A:V.482
D12.49: 8 residues within 4Å:- Chain B: L.881, I.882, F.885, W.895, S.896, F.899, F.1033
- Ligands: OCT.58
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:F.885, B:W.895, B:F.899, B:F.899, B:F.1033, B:F.1033
D12.50: 11 residues within 4Å:- Chain B: V.382, F.386, V.454, A.457, F.458, R.468, I.472, V.475, S.476, A.479
- Ligands: HEX.52
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:F.386, B:F.386, B:A.457, B:F.458, B:F.458, B:I.472
- 8 x HEX: HEXANE(Non-functional Binders)(Non-covalent)
HEX.19: 4 residues within 4Å:- Chain A: M.1, L.483
- Ligands: D12.20, HEX.23
No protein-ligand interaction detected (PLIP)HEX.23: 6 residues within 4Å:- Chain A: M.1, F.4, F.5, I.15, I.487
- Ligands: HEX.19
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:F.4
HEX.51: 6 residues within 4Å:- Chain B: F.899, L.903, V.1028, V.1029, R.1032, F.1033
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:L.903
HEX.52: 8 residues within 4Å:- Chain B: A.446, S.450, V.454, V.475, M.478, A.479
- Ligands: LMT.37, D12.50
No protein-ligand interaction detected (PLIP)HEX.57: 5 residues within 4Å:- Chain B: M.1, F.4, F.5, F.11, I.15
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:F.4
HEX.61: 4 residues within 4Å:- Chain A: F.458
- Chain C: A.384, A.385
- Ligands: D12.18
No protein-ligand interaction detected (PLIP)HEX.86: 7 residues within 4Å:- Chain C: M.1, V.443, A.479, V.482, L.483, L.486
- Ligands: LMT.68
2 PLIP interactions:2 interactions with chain C- Hydrophobic interactions: C:L.483, C:L.486
HEX.87: 0 residues within 4Å:- (No contacts)
No protein-ligand interaction detected (PLIP)- 1 x XE9: [3-(3-chloranyl-2-piperazin-1-yl-quinolin-6-yl)phenyl]methanamine(Non-covalent)
XE9.22: 18 residues within 4Å:- Chain A: L.404, L.405, D.407, D.408, V.411, Q.437, I.438, A.441, L.442, I.445, A.446, L.449, K.940, I.943, L.944, E.947, F.948, D.951
9 PLIP interactions:9 interactions with chain A- Hydrophobic interactions: A:V.411, A:I.438, A:I.445, A:L.944, A:E.947
- Hydrogen bonds: A:D.408, A:E.947
- pi-Stacking: A:F.948
- Halogen bonds: A:K.940
- 2 x D10: DECANE(Non-covalent)
D10.24: 8 residues within 4Å:- Chain A: I.19, A.22, G.378, A.381, V.382, A.384, A.385, L.480
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:A.381
D10.32: 7 residues within 4Å:- Chain B: P.9, I.10, W.13, I.17, M.20
- Chain C: W.895
- Ligands: LPX.67
5 PLIP interactions:1 interactions with chain C, 4 interactions with chain B- Hydrophobic interactions: C:W.895, B:I.10, B:W.13, B:W.13, B:I.17
- 1 x DDR: (2S)-3-hydroxypropane-1,2-diyl didecanoate(Non-covalent)
DDR.35: 25 residues within 4Å:- Chain B: V.448, V.452, P.455, M.456, F.459, Y.467, M.552, F.556, L.876, Y.877, S.880, L.881, V.884, L.888, V.901, M.902, V.904, V.905, P.906, V.909, Q.928, L.931, L.932, I.935, A.939
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:Y.877, B:L.881, B:V.884, B:V.905, B:L.932, B:L.932, B:I.935, B:A.939
- Hydrogen bonds: B:L.876
- 2 x DDQ: DECYLAMINE-N,N-DIMETHYL-N-OXIDE(Non-covalent)
DDQ.42: 13 residues within 4Å:- Chain A: F.4, R.8, F.11, V.14, I.18
- Chain B: Q.439, G.440, V.443, G.444, M.447, C.887, A.890, L.891
5 PLIP interactions:3 interactions with chain A, 2 interactions with chain B- Hydrophobic interactions: A:F.11, A:F.11, B:V.443, B:A.890
- Hydrogen bonds: A:R.8
DDQ.88: 7 residues within 4Å:- Chain A: W.895
- Chain C: W.13, I.17, M.20, R.363, M.496
- Ligands: OCT.3
No protein-ligand interaction detected (PLIP)- 3 x SO4: SULFATE ION(Non-functional Binders)
SO4.43: 5 residues within 4Å:- Chain B: Y.356, N.361, F.362, R.363, K.498
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:F.362, B:R.363
- Salt bridges: B:K.498
SO4.73: 4 residues within 4Å:- Chain C: K.55, G.691, H.692, E.693
2 PLIP interactions:2 interactions with chain C- Hydrogen bonds: C:H.692
- Salt bridges: C:K.55
SO4.79: 7 residues within 4Å:- Chain C: T.44, Q.89, T.91, S.132, S.133, S.134, K.292
5 PLIP interactions:5 interactions with chain C- Hydrogen bonds: C:T.44, C:T.91, C:S.132
- Water bridges: C:S.133
- Salt bridges: C:K.292
- 2 x LPX: (2S)-3-{[(R)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-hydroxypropyl hexadecanoate(Non-covalent)
LPX.65: 18 residues within 4Å:- Chain C: I.19, P.36, G.378, V.382, F.386, F.388, V.454, A.457, A.465, R.468, Q.469, S.471, I.472, V.475, S.476, A.479, L.480, L.483
8 PLIP interactions:8 interactions with chain C- Hydrophobic interactions: C:V.382, C:I.472, C:V.475, C:A.479
- Hydrogen bonds: C:Q.469, C:I.472
- Water bridges: C:Q.469
- Salt bridges: C:R.468
LPX.67: 13 residues within 4Å:- Chain B: I.10, I.17, L.21
- Chain C: I.882, F.885, L.886, S.894, W.895, S.896, R.1030, F.1033, S.1034
- Ligands: D10.32
13 PLIP interactions:11 interactions with chain C, 2 interactions with chain B- Hydrophobic interactions: C:I.882, C:I.882, C:F.885, C:L.886, C:W.895, C:W.895, B:I.17, B:L.21
- Hydrogen bonds: C:S.894, C:W.895, C:S.896, C:S.896, C:F.1033
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Boernsen, C. et al., Molecular mechanism of transition-state inhibitors of bacterial antibiotic efflux pumps. To Be Published
- Release Date
- 2025-11-12
- Peptides
- Multidrug efflux pump subunit AcrB: ABC
DARPIN: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.94 Å
- Oligo State
- hetero-3-2-mer
- Ligands
- 8 x LMT: DODECYL-BETA-D-MALTOSIDE(Non-covalent)
- 8 x OCT: N-OCTANE(Non-covalent)
- 2 x C14: TETRADECANE(Non-covalent)
- 14 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 39 x GOL: GLYCEROL(Non-functional Binders)
- 4 x D12: DODECANE(Non-covalent)
- 8 x HEX: HEXANE(Non-functional Binders)(Non-covalent)
- 1 x XE9: [3-(3-chloranyl-2-piperazin-1-yl-quinolin-6-yl)phenyl]methanamine(Non-covalent)
- 2 x D10: DECANE(Non-covalent)
- 1 x DDR: (2S)-3-hydroxypropane-1,2-diyl didecanoate(Non-covalent)
- 2 x DDQ: DECYLAMINE-N,N-DIMETHYL-N-OXIDE(Non-covalent)
- 3 x SO4: SULFATE ION(Non-functional Binders)
- 2 x LPX: (2S)-3-{[(R)-(2-aminoethoxy)(hydroxy)phosphoryl]oxy}-2-hydroxypropyl hexadecanoate(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Boernsen, C. et al., Molecular mechanism of transition-state inhibitors of bacterial antibiotic efflux pumps. To Be Published
- Release Date
- 2025-11-12
- Peptides
- Multidrug efflux pump subunit AcrB: ABC
DARPIN: DE - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
E - Membrane
-
We predict this structure to be a membrane protein.